Chronic sinusitis
Conditions
Interventions
Treatment Group: Precision Electroacupuncture Stimulation in the Pterygopalatine Fossa
Control Group:Standard Acupuncture Technique
Sponsors
Xiyuan Hospital of CACMS
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Clinical Trial 1.Clinical Diagnosis: Patients with a confirmed diagnosis of chronic rhinosinusitis. 2.Age: 18-65 years old. 3.Informed Consent: Subjects must provide written informed consent demonstrate full cooperation and sign the informed consent form. Database Construction 1.Inclusion Age: Patients aged 18-65 years. 2.Diagnostic Confirmation: Chronic rhinosinusitis must be definitively diagnosed; ambiguous descriptions (e.g. "suspected chronic rhinosinusitis" or statements with "?") are excluded. CT imaging must demonstrate mucosal thickening =0.5 cm in any sinus supported by definitive medical reports. 3.Imaging Quality: Only high-resolution CT (HRCT) scans with no significant artifacts are included. 4.CT Specifications: Scans must cover the complete nasal sinus regions (maxillary ethmoid frontal and sphenoid sinuses) with slice thickness =1 mm and consistent scanning parameters.
Exclusion criteria
Exclusion criteria: Clinical Trial Exclusion Criteria 1.Severe Comorbidities: Patients with severe conditions (e.g. cardiac disease renal failure major organ dysfunction) or coagulation disorders including those on long-term anticoagulant therapy. 2.Acute Infections or Skin Conditions: Individuals with acute sinusitis other acute infections or skin lesions at needle insertion sites. 3.Pregnancy and Lactation: Exclude pregnant or lactating individuals as well as those planning pregnancy within the next year. 4.Allergy History: Patients with documented allergies to materials used in acupuncture (e.g. metal needles alcohol). 5.Prior Surgery: Patients with a history of nasal or sinus surgery (e.g. polypectomy septoplasty sinusotomy) that may confound treatment outcomes. 6.Medication Interference: Participants using systemic corticosteroids or antibiotics that could affect efficacy assessments. 7.Cognitive or Psychiatric Disorders: Patients unable to provide informed consent due to cognitive impairment or psychiatric conditions. 8.Recent Trial Participation: Exclusion of individuals enrolled in other clinical trials within the past 60 days to avoid crossover effects. Database Construction Exclusion Criteria 1.Surgical History: Exclude patients with prior nasal/sinus surgery verified via medical records and CT reports. 2.Poor Imaging Quality: Cases with CT artifacts blurring or incomplete anatomical coverage of key sinus structures (e.g. maxillary ethmoid frontal sphenoid sinuses). 3.Confounding Pathologies: Patients with unrelated systemic diseases (e.g. tumors) or imaging findings that obscure sinus evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sino-nasal outcome test-22; | — |
Secondary
| Measure | Time frame |
|---|---|
| Deep learning-based calculation of intranasal turbidity volume;Lund-Mackay;VAS; | — |
Countries
China
Contacts
Public ContactZhang lu
Xiyuan Hospital of CACMS
Outcome results
None listed